CAMBRIDGE, Mass. - June 23, 2016 - PRLog -- Statement from Dr. Mark G. Charest: "Harvard University and I have settled our ongoing litigation regarding the allocation of royalties related to the license with Tetraphase Pharmaceuticals on mutually agreeable terms. In light of my claims and goals in bringing this litigation, I am very pleased to accept terms I view as equitable."
The title of Dr. Charest's case is Mark G. Charest v. The President and Fellows of Harvard College, 1:13-cv-11556-DJC. This case was filed on June 28, 2013 in United Stated District Court for the District of Massachusetts and recently settled.
Dr. Mark G. Charest is represented by Brian D. O'Reilly of O'Reilly IP PLLC, One Grand Central Place, 60 East 42nd Street, Suite 2520, New York, NY 10165. Mr. O'Reilly is a member of the Massachusetts and New York bar. O'Reilly IP represents individuals and small companies against larger companies and institutions in patent matters on a contingency basis. He can be reached at 212 390-0096 and at brian@oreillyip.com. www.oreillyip.com
Media Contact
Brian D. O'Reilly
O'Reilly IP PLLC
brian@oreillyip.com
Read Full Story - Harvard University and Dr. Mark G. Charest settle litigation regarding the allocation of patent royalties | More news from this source
Press release distribution by PRLog
Harvard University and Dr. Mark G. Charest settle litigation regarding the allocation of patent royalties
June 23, 2016 at 11:29 AM EDT
